Skip to main content
PMC home page
The Journal of General Physiology logoLink to The Journal of General Physiology
. 1970 Aug 1;56(2):250–271. doi: 10.1085/jgp.56.2.250

Threshold and Receptor Reserve in the Action of Neurohypophyseal Peptides

A study of synergists and antagonists of the hydroosmotic response of the toad urinary bladder

Patrick Eggena 1, Irving L Schwartz 1, Roderich Walter 1
PMCID: PMC2225856  PMID: 5433469

Abstract

The interrelationship of several physiological receptors which influence the hydroosmotic response of the toad urinary bladder was studied employing neurohypophyseal peptides, prostaglandin E1, theophylline, and cyclic nucleotides. The binding property of agonists (pD 2), synergists (pS 2), competitive antagonists (pA 2), and noncompetitive antagonists (pD 2') was determined after a suitable methodology had been developed. A series of neurohypophyseal peptides was examined in detail for their catalytic activity. It was found that the replacement of the hydroxy radical of the tyrosine residue in oxytocin by a methoxy and then by an ethoxy radical led to a progressive decline in the catalytic activity of the hormone—corresponding to a change from agonist to partial agonist to competitive antagonist. [4-Leucine]-mesotocin behaved as a competitive antagonist of oxytocin. Prostaglandin E1 (PGE1) was found to be a noncompetitive inhibitor of neurohypophyseal peptides and theophylline; whereas the maximal hydroosmotic response of the bladder to [2-O-methyltyrosine]-oxytocin and theophylline was greatly depressed by PGE1, the response to saturating concentrations of oxytocin was only slightly diminished—a finding which reveals a "receptor reserve" for oxytocin. Saturating concentrations of [2-O-ethyltyrosine]-oxytocin, inactive per se, potentiate theophylline—disclosing a "threshold phenomenon" for the mediation of neurohypophyseal hormone action. It is concluded that neurohypophyseal peptides are capable of producing graded effects on adenyl cyclase both below and above the range of enzyme activity which evokes graded changes in membrane permeability.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACHER R., CHAUVET J., CHAUVET M. T., CRERY D. PHYLOG'ENIE DES PEPTIDES NEUROHYPOPHYSAIRES: ISOLEMENT DE LA MESOTOCINE (ILEU 8-OCYTOCINE) DE LA GRENOUILLE, INTERM'EDIAIRE ENTRE LA SER-4-ILEU 8-OCYTOCINE DES POISSONS OSSEUX ET L'OCYTOCINE DES MAMMIF'ERES. Biochim Biophys Acta. 1964 Sep 4;90:613–615. [PubMed] [Google Scholar]
  2. ARIENS E. J. Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory. Arch Int Pharmacodyn Ther. 1954 Sep 1;99(1):32–49. [PubMed] [Google Scholar]
  3. ARIENS E. J., SIMONIS A. M., VAN ROSSUM J. M. A theoretical basis of molecular pharmacology. III. Interaction of one or two compounds with two independent receptor systems. Arzneimittelforschung. 1956 Dec;6(12):737–746. [PubMed] [Google Scholar]
  4. ARIENS E. J., VAN ROSSUM J. M., SIMONIS A. M. A theoretical basis of molecular pharmacology. I. Interactions of one or two compounds with one receptor system. Arzneimittelforschung. 1956 May;6(5):282–293. [PubMed] [Google Scholar]
  5. ARIENS E. J., VAN ROSSUM J. M. pDx, pAx and pDx values in the analysis of pharmacodynamics. Arch Int Pharmacodyn Ther. 1957 Apr 1;110(2-3):275–299. [PubMed] [Google Scholar]
  6. ARIENS E. J., van ROSSUM J., KOOPMAN P. C. Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs. Arch Int Pharmacodyn Ther. 1960 Sep 1;127:459–478. [PubMed] [Google Scholar]
  7. BENTLEY P. J. The effects of neurohypophysial extracts on the water transfer across the wall of the isolated urinary bladder of the toad Bufo marinus. J Endocrinol. 1958 Sep;17(3):201–209. doi: 10.1677/joe.0.0170201. [DOI] [PubMed] [Google Scholar]
  8. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  9. Butcher R. W., Baird C. E. Effects of prostaglandins on adenosine 3',5'-monophosphate levels in fat and other tissues. J Biol Chem. 1968 Apr 25;243(8):1713–1717. [PubMed] [Google Scholar]
  10. Chan W. Y., Hruby V. J., Flouret G., Du Vigneuad V. 4-Leucine-oxytocin: natriuretic, diuretic, and antivasopressin polypeptide. Science. 1968 Jul 19;161(3838):280–281. doi: 10.1126/science.161.3838.280. [DOI] [PubMed] [Google Scholar]
  11. Eggena P., Schwartz I. L., Walter R. A sensitive hydroosmotic toad bladder assay. Affinity and intrinsic activity of neurohypophyseal peptides. J Gen Physiol. 1968 Sep;52(3):465–481. doi: 10.1085/jgp.52.3.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ferrier B. M., Jarvis D., Du Vigneaud V. Deamino-oxytocin. Its isolation by partition chromatography on Sephadex and crystallization from water, and its biological activities. J Biol Chem. 1965 Nov;240(11):4264–4266. [PubMed] [Google Scholar]
  13. Gulyassy P. F. Metabolism of adenosine 3',5'-monophosphate by epithelial cells of the toad bladder. J Clin Invest. 1969 Nov;47(11):2458–2468. doi: 10.1172/JCI105928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HAYS R. M., LEAF A. Studies on the movement of water through the isolated toad bladder and its modification by vasopressin. J Gen Physiol. 1962 May;45:905–919. doi: 10.1085/jgp.45.5.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Havran R. T., Schwartz I. L., Walter R. Oxytocin analogs with basic amino acid residues in positions 4 and 5. Synthesis and pharmacological properties of [4-ornithine]- and [5-ornithine]-oxytocin. J Am Chem Soc. 1969 Mar 26;91(7):1836–1840. doi: 10.1021/ja01035a040. [DOI] [PubMed] [Google Scholar]
  16. Horton E. W. Hypotheses on physiological roles of prostaglandins. Physiol Rev. 1969 Jan;49(1):122–161. doi: 10.1152/physrev.1969.49.1.122. [DOI] [PubMed] [Google Scholar]
  17. KIRSCHNER L. B., STONE W. E. Action of inhibitors at the myoneural junction. J Gen Physiol. 1951 Jul;34(6):821–834. doi: 10.1085/jgp.34.6.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. NICKERSON M. Receptor occupancy and tissue response. Nature. 1956 Sep 29;178(4535):697–698. doi: 10.1038/178697b0. [DOI] [PubMed] [Google Scholar]
  19. ORLOFF J., HANDLER J. S., BERGSTROM S. EFFECT OF PROSTAGLANDIN (PGE-1) ON THE PERMEABILITY RESPONSE OF TOAD BLADDER TO VASOPRESSIN, THEOPHYLLINE AND ADENOSINE 3',5'-MONOPHOSPHATE. Nature. 1965 Jan 23;205:397–398. doi: 10.1038/205397a0. [DOI] [PubMed] [Google Scholar]
  20. ORLOFF J., HANDLER J. S. The similarity of effects of vasopressin, adenosine-3',5'-phosphate (cyclic AMP) and theophylline on the toad bladder. J Clin Invest. 1962 Apr;41:702–709. doi: 10.1172/JCI104528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Orloff J., Handler J. The role of adenosine 3',5'-phosphate in the action of antidiuretic hormone. Am J Med. 1967 May;42(5):757–768. doi: 10.1016/0002-9343(67)90093-9. [DOI] [PubMed] [Google Scholar]
  22. Robison G. A., Butcher R. W., Sutherland E. W. Cyclic AMP. Annu Rev Biochem. 1968;37:149–174. doi: 10.1146/annurev.bi.37.070168.001053. [DOI] [PubMed] [Google Scholar]
  23. Rudinger J., Kesarev O. V., Poduska K., Pickering B. T., Dyball R. E., Ferguson D. R., Ward W. R. (4-proline, 8-isoleucine)-oxytocin and (4-leucine, 8-isoleucine)-oxytocin, possible intermediates in the evolutionary series of neurophypophysial hormones: synthesis and some pharmacological properties. Experientia. 1969;25(7):680–682. doi: 10.1007/BF01897555. [DOI] [PubMed] [Google Scholar]
  24. STEPHENSON R. P. A modification of receptor theory. Br J Pharmacol Chemother. 1956 Dec;11(4):379–393. doi: 10.1111/j.1476-5381.1956.tb00006.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schild H. O. pA, a new scale for the measurement of drug antagonism. 1947. Br J Pharmacol. 1997 Feb;120(4 Suppl):29–28. doi: 10.1111/j.1476-5381.1997.tb06773.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schwartz I. L., Rasmussen H., Schoessler M. A., Silver L., Fong C. T. RELATION OF CHEMICAL ATTACHMENT TO PHYSIOLOGICAL ACTION OF VASOPRESSIN. Proc Natl Acad Sci U S A. 1960 Oct;46(10):1288–1298. doi: 10.1073/pnas.46.10.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Waud D. R. Pharmacological receptors. Pharmacol Rev. 1968 Jun;20(2):49–88. [PubMed] [Google Scholar]
  28. van ROSSUM J., ARIENS E. J. Receptor-reserve and threshold-phenomena. II. Theories on drug-action and a quantitative approach to spare receptors and threshold values. Arch Int Pharmacodyn Ther. 1962 Apr 1;136:385–413. [PubMed] [Google Scholar]

Articles from The Journal of General Physiology are provided here courtesy of The Rockefeller University Press

RESOURCES